24-hour urinary 5-hydroxyindole acetic acid excretion in patients with ulcerative colitis;Wydalanie kwasu 5-hydroksyindolooctowego z moczem u osób z wrzodziejacym zapaleniem jelita grubego

Polski Merkuriusz Lekarski

Volumn 26, Issue 155, 2009, Pages 452-454

  Wiśniewska Jarosińska, Maria ^a   Boznańska Świetaszek, Patrycja ^a   Harasiuk, Agnieszka ^a   Mokwińska, Marzena ^a   Stec Michalska, Krystyna ^a   Chojnacki, Jan ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

5 hydroxyindole acetic acid; Serotonin; Ulcerative colitis

Indexed keywords

5 HYDROXYINDOLEACETIC ACID;

ADULT; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; PREDICTION AND FORECASTING; REFERENCE VALUE; ULCERATIVE COLITIS; URINE;

ADULT; COLITIS, ULCERATIVE; FEMALE; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES;

EID: 67949111180     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bearcroft C.P., Parret D., Farthing M.J.: Postprandial plasma 5-hydroxy-tryptamine in diarrhoea predominant irritable bowel syndom: a pilot study. Gut, 1998,42,42-46.
2. Camilleri M.: Serotonergic modulationofvisceral sensation: lower gut. Gut , 2002, 51-81-86.
3. Coates M.D., Mahoney C.R., Linden D.R. et al.: Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology, 2004, 126, 1657-1664.
4. Crowell M.D.: Role of serotonin in the pathophysiology of irritable bowel syndrome. Br. J. Pharmacol. , 2004, 141, 1285-1293.
5. Dunlop S.P., Coleman S., Blackshaw E. et al.: Abnormalities of 5-hydro-xytryptamine metabolism in irritable bowel syndrome. Clin. Hepatol. Gastroenterol. , 2005, 3, 349-357.
6. El-Salhy M., Norrgard O., Spineli S.: Abnonnal colonic cells in patients with chronic idiopathic slow-transit constipation. Scand. J. Gastroenterol., 1999,34, 1007-1011.
7. El-Salhy M., Danielson A., Sterling R., Grimelinski.: Colonic endocrine cells in inflammatory bowel disease. J. Intern. Med., 1997, 242, 413-419.
8. Foley K.F., Pantano C, Ciolino A., Mawe G.M.: IFN-gamma and TNF-alfa decrease seronin transporter function and expression in Caco2 cells. Am. J. Physiol. Gastrointest. Liver. Physiol., 2007, 292, 279-284.
9. Gershon M.D.: Serotonin receptors and transoporters-role in normal and abnormal gastrointestinal motility. Aliment. Pharmacol. Ther., 2004, 20, 3-14.
10. Houghton L.A., Atkinson W., Whitaker R.P. et al.: Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut, 2003, 52, 663-670.
11. Linden D.R., Foley K.F., McQuoid C. et al.: Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis. Neuro-gastroenterol. Motil., 2005, 17, 565-574.
12. Magro F, Vieira-Coelho M.A, Fraga S. et al.: Impaired synthesis of cellular storage of norepinephrine, dopamine and 5-hydroxytryptamine in human inflammatory bowel disease. Dig. Dis. Sci., 2002, 47, 216-224.
13. Miwa J., Echizen H., Matsueda K. et al.: Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentration in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion, 2001, 63, 188-194.
14. Moskwa A., Chojnacki J., Wiśniewska-Jarosińska M. i wsp.: Stȩżenie serotoniny w surowicy krwi i wydalanie kwasu 5-hydroksyindolooctowe-go z moczem u osób z zespołem jelita nadwrażliwego. Pol. Merk. Lek., 2007, 131. 366-368.
15. O'Hara J.R., Ho W., Linden D.R. et al.: Endocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS colitis. Am. J. Physiol., Gastrointest. Liver. Physiol., 2004, 287, 958-1007.
16. Osadchuk A.M., Osadchuk M.A., Balashov A.V., Kwetnoi I.M.: The role of diffuse system and colonocytes cellular renovation information of clinical variants of irritable(colonocytes)in young patients. Klin. Med., 2008; 86(3), 33-37.
17. Rybakowa M.G, , Botina A.V., Socowera O.J.: Immuno-morphological characteristic of mucosal and endocrine cells of the colon in patients with chronic ulcerative colitis. Arkh. Patol., 2005, 67, 30-33.
18. Shen B., Liu W., Remzi FA. et al.: Enterochromaffin cells hyperlasia in irritable pouch syndrome. Am. J. Gastroenterol., 2008,103(9), 2293-2300.
19. Spiller R.: Serotonergic modulating drugs for functional gastrointestinal disease. J. Clin. Pharmacol., 2002, 54, 11-20.
20. Spiller R.C., Jenkins D., Thornley J.P. et al.: Increased rectal mucosal enteroendocrine, T-lymphocytes and increased gut permeability following acute Campylobacter enteritis and post dysenteric irritable bowel syndrome. Gut, 2000, 47, 804-811.